Washington, Oct 28: Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine to the COVAX Facility, a collaboration designed to give countries around the world equal access to coronavirus vaccines.
Search
Health & Food
Houston: Indian and Pakistani women are diagnosed with breast cancer, including more aggressive forms, at a younger age, according to a study that provides an insight into understanding the risk factors influencing the disease.
Antibodies against the novel coronavirus follow a classic pattern with a rapid increase within the first three weeks after symptoms, and detectable up to seven months post contracting the disease, according to a new study which assessed 300 patients infected with the virus and 198 post-COVID-19 volunteers.
Washington, Oct 24: The initial phase of the COVID-19 lockdown, which was imposed through March and April in several countries, may have dramatically altered people's personal eating and sleeping habits, according to a new study based on a first-of-its-kind global survey.
While transmission of the novel coronavirus as small aerosol particles is more significant in summer, direct contact with respiratory droplets may be more pronounced in the winter months, according to a new research.
New Delhi, Oct 13: The World Health Organization has debunked the idea of herd immunity, saying it is 'scientifically and ethically problematic' and is not an option.
New Brunswick, Oct 13: A late-stage study of Johnson & Johnson's COVID-19 vaccine candidate has been paused while the company investigates whether a study participant's unexplained illness is related to the shot.
The Covid-19 vaccines closest to the finish line are designed to be injected into the arm. Researchers are looking at whether they can get better protection from inoculations that fight the virus at its point of attack — the nose and mouth.
Pune, Oct 11: Bharat Biotech, which had sought DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing some clarifications, before proceeding for the next stage.
Bengaluru, Oct 9: Researchers from the Indian Institute of Science (IISc) said they have developed a non- invasive bandage made with magnetic nanofibres to treat skin cancer by administering heat to the tumour cells.